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Gastrointestinal developmentHedgehog (Hh) signaling is critical for embryonic development and in differentiation, proliferation, and
maintenance of multiple adult tissues. De-regulation of the Hh pathway is associated with birth defects and
cancer. In the gastrointestinal tract, Hh ligands Sonic (Shh) and Indian (Ihh), as well as the receptor Patched
(Ptch1), and transcription factors of Glioblastoma family (Gli) are all expressed during development. In the
adult, Shh expression is restricted to the stomach and colon, while Ihh expression occurs throughout the
luminal gastrointestinal tract, its expression being highest in the proximal duodenum. Several studies have
demonstrated a requirement for Hh signaling during gastrointestinal tract development. However to date,
the speciﬁc role of the Hh pathway in the adult stomach and intestine is not completely understood. The
current review will place into context the implications of recent published data related to the biochemistry
and cell biology of Hh signaling on the luminal gastrointestinal tract during development, normal physiology
and subsequently carcinogenesis.and Molecular & Integrative
bor, MI 48109-2200, USA. Tel.:
).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.Hedgehog (Hh) signaling is critical during embryonic develop-
ment. It is involved in the patterning of the neural tube, lung, skin,
axial skeleton, and gastrointestinal tract [1–3] (reviewed in [4] and
[5]). In multiple adult tissues, Hh signaling remains active and
contributes to differentiation, proliferation, and maintenance. By
contrast, deregulation of the Hh pathway is associated with birth
defects and cancer (reviewed in [6], [7–9]). Speciﬁcally, Hh signaling
is constitutively active in medulloblastoma, basal cell carcinoma,
small cell lung cancer, breast, pancreas, and gastric cancer. As a result,
phase 2 clinical trials for Hh signaling inhibitor GDC-0449 are
underway for basal cell [10], medulloblastoma [11], ovarian [12],
pancreatic, and metastatic colon cancers (Curis & Genentech).
Although a number of reviews on the Hh pathway and cancer have
been published, most have focused on extra-gastrointestinal cancers.
In addition, new information related to the biochemistry and cell
biology of Hh signaling is rapidly accumulating. Therefore the current
review will attempt to place into context the implications of this new
information for the luminal gastrointestinal tract, during develop-
ment, normal physiology and subsequently carcinogenesis.
1. Ligands, Receptors, Signal Transduction
There are three members of the mammalian Hh family: Sonic
(Shh), Indian (Ihh), and Desert (Dhh) [13,14]. All the ligands bind
with similar afﬁnity to a 12-transmembrane receptor called Patched(Ptch1) that restricts Hh signaling by inhibiting a 7-transmembrane
receptor called Smoothened (Smo) [15]. The cytoplasmic tail of Smo
serves as a nidus for the accumulation of the Glioblastoma tran-
scription factor protein family (Gli) held in a complex with regulatory
proteins, e.g. Costal 2 (Cos), Fused (Fu) and Suppressor of Fused
(Sufu) [16]. Upon binding of ligand to Ptch1, the inhibition on Smo is
removed and processed forms of Gli migrate to the nucleus to bind Hh
target genes ([17–19], reviewed in [5,6,20]). Of the three Hh ligands,
Shh is most related to its Drosophila homolog and has been studied
most intensively [21]. Thus, we will focus on Shh except where noted.
Shh ligand is expressed as a ∼45 kilodalton (kDa) precursor that is
cleaved autocatalytically, yielding a 19 kDa amino terminal form, and
a residual 26 kDa carboxy-terminal form that acts as a cholesterol
transferase. In the stomach, Shh processing depends on the acid-
activated protease pepsin [22]. However, whether protease-cleaved
Shh is lipid modiﬁed and occurs in other tissues has not yet been
determined. The ﬁnal Shh protein is cholesterol modiﬁed at a C-
terminal cysteine and palmitoylated at its amino terminus [23]. These
post-translational hydrophobic modiﬁcations facilitate long-range
signaling despite their intrinsically poor solubility [24,25]. Although
poor solubility and long-range signaling appear counterintuitive,
Grobe and coworkers, shed light on this concept by demonstrating
that Shh forms stable high molecular weight oligomers with high
biological activity [26,27]. Additionally, the lipid modiﬁed-Hh inter-
acts with cell-secreted proteoglyglans [28,29], heparan [27], and
chondroitin sulfates [30], the latter two have been associated with
proper Shh and Ihh signalining respectively. Under-sulfated proteo-
glycans or Shh mutated in the proteoglycan interaction domain
impair Hh signaling of various developmental stages during mouse
embryogenesis, resulting in decreased proliferation of chondrocytes
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mouse embryos, proteoglycans and heparan sulfate facilitate the
distribution on tissues to reach target cells, and on the internalization
of the Hh-Ptch1 complex by the cell [31,32]. However the role of
proteoglycans has only be examined during neural central tube de-
velopment. There are no functional studies examining the role of
these molecules in adult Hh signaling.
ADAM17 andmetalloproteases appear to be involved in Hh release
from the producing cell, along with Dispatched, a 12-transmembrane
protein with a sterol-sensing domain. To test its function, Dispatched
null mice were examined and showed a phenotype similar to mice
lacking Smo, i.e., embryonic lethality [33–37]. The authors concluded
that Dispatched is necessary for the release of cholesterol-modiﬁed
Hh, and that this modiﬁcation regulates Hh signaling in the de-
veloping nervous system [37], bone [38], and limb bud [39]. To our
knowledge, there are no studies addressing the role of Dispatched in
adult tissues. We [22,40] and others [41–43] have shown in vitro that
recombinant Shh exhibits regulatory activity, albeit at a lower potency
compared to tissue generated Shh presumably because it is not lipid-
modiﬁed as endogenous Shh [22]. Indeed, Robbins and coworkers
have found some Shhmutations in holoprosencephaly patients, which
are inactive or exhibit low-activity function as dominant-negative
ligands [44], suggesting that variable Shh activity contributes to
different phenotypes.
Hh ligands bind to Ptch1, which itself contains a cholesterol-
binding domain. Vertebrates have Ptch1 [45] and Ptch2 [46] variants.
Ptch1 is a transcriptional target of Hh signaling and acts by repressing
Smo [15]. The speciﬁcity of Ptch1 is somewhat controversial since its
function depends on the cell type, and protein domain involved
[47,48]. Hematopoietic cell-speciﬁc deletion of Ptch1 does not result
in constitutively active Hh signaling [49], as Hh signaling has recently
been shown to be dispensable for hematopoiesis [50,51], whereas in
skin, brain and colon, mutations in Ptch1 result in unregulated Hh
signaling causing basal cell carcinoma of the skin [52,53], medullo-
blastoma of the brain [54,55], and Gorlin syndrome [56,57], an
autosomal dominant disorder characterized by the early appearance
of basal cell carcinomas and cancers in other organs, e.g., brain, colon
and ovary.
In the presence of Hh ligands, the repression of Smo by Ptch1 is
relieved [58,59], activated Smo accumulates in primary cilia and Hh
signaling is initiated [60]. In addition to Ptch1, other membrane
proteins have been identiﬁed that can bind to Hh ligands to modulate
signaling. Hip (Hh interacting protein) is the best studied [61,62].
Recently Gas1 (growth arrest speciﬁc gene 1) [63–66], Cdo (CAM
related/down regulated by oncogene) [67] and BOC (brother of Cdo)
[68] have been reported to modulate Hh signaling during develop-
ment [69], including the gastrointestinal tract [70,71]. However their
expression and possible function in adult tissues has not been
established, though expression of Cdo and BOC messenger RNA has
been demonstrated in normal stomach and gastric cancer samples by
RT-PCR [72].
Once Smo is released from the inhibiting inﬂuence of Ptch1, it
translocates to primary cilia andmediates the activation of Gli proteins
[73]. In the absence of Hh ligands, Gli proteins are sequestered in the
cytoplasm in a complex containing the kinesin-related protein Kif7,
the mammalian homolog of Drosophila Cos2 [74,75]; the serine/
threonine kinase Fu, and Sufu [76–78]. As a complex, Kif7 and Fu direct
the proteosomal degradation of the full length Gli protein to its
repressor form [79,80]. Gli proteins contain a C-terminal zinc ﬁnger
DNA binding domain and a N-terminal repressor domain (R) [81],
which translocates to the nucleus to suppress the expression of Hh
targets [18].
The mechanism of Ptch1 repression on Smo is not completely
understood, though involvement of 7-dehydrocholesterol (provita-
min D3) secretion has been suggested [15]. Also, a recent report has
shown that Tow (target of Wingless) protein, is a modulator of Hhsignaling that acts downstream of Ptch1 but upstream of Smo. Tow is a
Drosophila homolog of a previously uncharacterized protein family
that controls the availability of Smo by regulating the degradation of
lipophorin particles [82]. Homologs of Tow have only been identiﬁed
in insects [83] however; proteins with similar functions may exist in
vertebrates. Tow is suppressed by wingless, and its over-expression
causes planar cell polarity defects [83]. Thus at least in insects, Hh
signaling appears to be suppressed by the Wnt pathway.
Ligand-mediatedde-repression of Smo stabilizes full lengthGli that
transactivates some Hh targets, e.g., Ptch1, Gli1, N-myc, and Wnt5a.
Other Hh target genes require further cleavage of Gli to produce a N-
terminally-derived activator (Gli-A) before their translocation to the
nucleus. Gli2 and Gli3, but not Gli1, are further processed from full-
length forms via phosphorylation at different residues primarily by
PKA, which results in the release of the activator forms [19]. Therefore
Gli 2 and 3 proteins are capable of target gene activation or repression.
The genes targeted by Hh signal transduction depend on whether
the promoters are occupied by the Gli activator or repressor form. Gli1
and Ptch1 are the classic genes activated by Hh signaling, e.g., Gli2-A
[84]. Moreover, Gli2 appears to be the key transcriptional effector of
Hh signaling in skin and other organs, including the stomach [85–90].
Studies in epidermal cells have groupedHh target genes in to 3 classes:
Class I are those genes in which expression is controlled by the Gli-R
form (i.e. Pax3); Class II promoters are inﬂuenced by both activator
and repressor forms, and their expression might be regulated in a
signal inducible manner (i.e. Ptch1, Cyclin D1, N-myc). Class III genes
are only induced by Gli-A forms (i.e. Gli1, Wnt5a) [91,92].
Primary cilia are necessary to process full-length Gli to Gli-R in the
absence of Hh ligand [93,94]. By contrast, Sufu is required for maximal
Hh signaling, modulating Hh-target genes in mouse embryonic ﬁbro-
blasts and during neural tube development [95–97]. Recent studies
have demonstrated that Gli processing not only depend on Smo
activation, but is also actively regulated by the negative Hh regulator
Sufu. Kise et al. showed that Sufu functions as a recruiter for GSK3b,
the kinase participating in Gli3 processing in the presence of Hh [80].
Furthermore, Chen et al. demonstrated that Sufu antagonizes the
activity of Speckle-type POZ/BTB protein (Spop), the mammalian
homolog of the Drosophila Hh-induced BTB domain protein Hib, that
acts as a Gli-degrading factor [98]. Therefore Sufu prevents the
processing of the full-length Gli2 and Gli3 proteins so that they are
available for processing in a cilia-independent manner [99,100].
Further studies on the cytoplasmic proteins involved in Hh pathway
signaling will provide some understanding of the signal transduction
regulations, particularly in adult tissues.
2. Hedgehog signaling in cancer
Hh signaling is not only important during development, but it also
has implications in the maintenance of adult tissues. Its deregulation
can lead to the development of several cancers, which are now the
focus of Phase II clinical trials. Rubin and de Sauvage proposed three
basic models for Hh pathway activity in cancer. Type I cancers, e.g.,
basal cell carcinomas, are ligand-independent because they involve
constitutive activation of either the receptor or downstream signaling
molecules. Type II cancers (e.g., pancreatic cancers) are ligand-
dependent, implying that they involve autocrine or juxtacrine
signaling mechanisms. Autocrine or juxtacrine means that the Hh-
producing and responding cells are either the same cell (autocrine) or
originate from adjacent tumor cells (juxtacrine). Type IIIa cancers are
also ligand-dependent, but exhibit paracrine signaling, i.e., tumor cells
produce Hh that activates downstream targets within the mesen-
chyme. Hh-activated mesenchymal cells produce proliferative signals
that feedback to the tumor to promote growth and survival [101].
Recently, these authors included a Type IIIb mechanism called
“reverse paracrine” signaling, where Hh ligands are generated from
mesenchymal cells, and received by responsive tumor cells in the
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the possibility of non-canonical signaling.
Non-canonical Hh signaling has been described in various studies.
Some studies have analyzed Ptch1 interaction with cyclin B1. Ptch1
and cyclin B1 have been shown to associate with cyclin dependent
kinase-1 (Cdk1) at the cell membrane in vitro (293T cells) [102] and in
vivo (human fetal kidney) [103], resulting in decreased proliferation,
and reduction of the mitotic index by the sequestration of the cyclin
B1/Cdk1 complex. These functions are antagonized by Shh, suggesting
that Ptch1 participates in a G2/M phase checkpoint independent of
other downstream Hh pathway components. Another report suggests
that activation of Ptch1 modulates apoptosis through activation of
caspase 3 by cleavage of the C-terminal cytoplasmic tail of Ptch1
[104,105]. Similarly, Shh blocks Ptch-mediated caspase cleavage.
Additionally, treatment of mouse ﬁbroblasts with soluble Shh induces
reorganization of the actin cytoskeleton, and the formation of
lamellipodia. These changes are observed during approximately the
ﬁrst 10 minutes of treatment before changes in Gli1 are observed,
suggesting that Shh can induce cell motility separate from the classic
canonical signaling through Gli1 [106]. On the other hand, TGFβ
signaling activates Gli2 independent of Hh ligands, which subsequent-
ly activates other gene targets, such as follistatin, an inhibitor of
stromal activins [107,108]. Nevertheless, the existence of non-
canonical signaling remains controversial primarily because the
evidence for this pathway depends completely upon the absence of
Gli1-mediated signaling assessed using a Gli1 reporter assay.
3. Primary Cilia
Primary cilia have been deﬁned as indispensable for Hh signaling
in mammalian cells [60,109]. Ptch1 blocks Smo localization to the cilia
in the absence of Shh. In the presence of the ligand, Smo migrates to
the primary cilia and then activates Gli proteins. In the skin, Shh is
expressed in hair follicles [110], while Ptch1 and Glis are expressed in
dermal ﬁbroblasts surrounding Shh secreting cells [90]. Primary cilia
are present in murine skin and hair follicles throughout morphogen-
esis, and during hair follicle cycling in postnatal life on both epithelial
and mesenchymal cells [111]. Purkinje cells in the brain and granule
precursor neurons express primary cilia too [112]. In these tissues, the
requirement of primary cilia in Hh signaling has been demonstrated.
In the pancreas and prostate not all cells express primary cilia.
However, there is synergy between Hh signaling and cilia positive
cells in these two organs [113–115].
Interestingly, some cancer types, and non-canonical Hh signals do
not require primary cilia. In basal cell carcinoma, the Hh pathway is
constitutively active in the absence of ligand due tomutations in Ptch1
or Smo [52,116,117]. Both medulloblastoma, and basal cell carcinoma
development can be associated with constitutively active Smo or Gli2.
In the case of Smo, primary cilia are necessary for pathway activation.
By contrast, cilia ablationwas required for these tumors to growwhen
constitutively active Gli2 was present [118,119].
We have observed the presence of primary cilia expressed in both
the gastric epithelium and mesenchyme (unpublished observations).
The presence of primary cilia in the gastric epithelium supports the
idea that both epithelial-epithelial, and epithelial-mesenchymal Hh
signaling might occur. Thus direction of Hh signaling in the gastric
mucosa should be viewed with some caution based on the presence
of primary cilia. Indeed, non-canonical signaling remains a possible
mechanism.
4. Hedgehog in the Gastrointestinal Tract
4.1. The Stomach
Within the luminal GI tract, Hh signaling in the adult stomach has
generated the greatest number of studies due to the original observationby Ramalho-Santos et al. who reported that there are metaplastic
changes in day old Shh null mice. Subsequently, a study comparing the
phenotype of Shh null to Gli 1, 2 or 3 null mice reported hyperplastic
rather than metaplastic changes since immunoﬂuorescent analysis of
the P0 stomachswere positive forH+,K+ATPase [120]. Interestingly, the
Gli3 null mice mimicked the Shh null phenotype in the stomach [120].
Until E15.5, Shh is expressed at high levels in the squamous forestomach
and anterior glandular stomach (Fig. 1). Shh expression tapers down
upon reaching the hindstomach (antrum), where Ihh is highly
expressed. Gli1 and Ptch1 expression mirrors the expression of Shh
[71]. Subsequently at E18.5, Shh and Ihh are expressed in the gastric
mucosa and decrease along the intestine [3,121]. By this time, Ptch1 and
Gli1 expression is restricted to the mesenchyme while in the embryo;
they are also present in the epithelium [122] (Fig. 1). The speciﬁc role of
Shh during gastric maturation is difﬁcult to deﬁne because Shh-/- mice
die in utero or within 24 h after birth when the gastric mucosa is not
completely differentiated and functional.
In the normal adult gastric corpus, Shh protein expression is
greatest in parietal cells (Table 1, Fig. 1). Recently using Shh-LacZ
reporter mice, we have shown that Shh mRNA is also expressed in
zymogenic, surface pit, and mucous neck cells, supporting previous
reports by other groups [40,72,123] (Table 1). In addition Shh mRNA
and protein expression and Hh signal transduction is observed in the
antrum [40]. This ﬁnding was surprising, as prior studies indicated no
Shh expression in the antrum [121].
There is controversy regarding how Hh signaling occurs in the
stomach. A major source of the controversy resides in the lack of
immunohistochemistry for Ptch1 and Gli to demonstrate that the
mRNA levels reﬂect protein expression. Most studies indicate that the
gastric epithelium secretes Shh and activates Hh receptors in the
mesenchyme. Both in situ hybridization, and Lac-Z reporter mice for
Ptch1 and Gli proteins show robust expression in the gastric
mesenchyme supporting this argument [71,124]. Berman et al.
showed that there is Ptch-LacZ expression in gastric parietal cells in
the gastric epithelium [125]. However other groups have not
reproduced their results. They also showed RNA expression of
Ptch1, Gli, Shh and Ihh in resected human tumor samples [125]. In
addition, Fukaya et al. demonstrated the expression of the three Hh
ligands and downstream signaling molecules by both immunohisto-
chemistry and RT-PCR analysis of tissues from human and mouse
gastric epithelium [123] (Table 1). Since this study was performed
using lasermicro dissection, contamination of the epithelial sample by
mesenchymal cells cannot be excluded.
Since Hh signaling is essential for the development of viable
embryos, deﬁning its role in adult tissues including the stomach
requires the use of cell speciﬁc knockouts. Unfortunately, there are very
few reliable tissue-speciﬁc promoters thatwill drive Cre recombinase in
the stomach. Zavros et al. recently used the H+,K+ATPase-β subunit
promoter, which faithfully drives Cre in gastric parietal cells to generate
a conditional Shh knockout [126]. These mice develop hypergastrine-
mia, an expanded mucous pit cell compartment and parietal cells
unresponsive to histamine stimulation. Interestingly, D cells (somato-
statin secreting cells), zymogenic and mucous neck cells populations
decreased.
Prior studies by Todisco and coworkers revealed that Shh
stimulates H+,K+ATPase gene expression [127]. Presumably, chemor-
eceptors on D cells detect the increase in pH (hypochlorhydria),
triggering a regulatory feedback loop that results in a decrease in
somatostatin and hypergastrinemia [128]. In point of fact, we pre-
viously showed that the loss somatostatin in null mice is the most
potent inducer of gastrin gene expression [129]. Since bona ﬁde
chemoreceptors have never been identiﬁed, the D cell regulation by
Shh functioning as a proton-sensing molecule might also explain the
acid-mediated feedback regulation. Conﬁrmation of this model awaits
demonstration that D cells directly respond to Hh signaling. Another
important observation is that loss of Shh did not cause parietal cell
Fig. 1. Expression of hedgehog pathwaymolecules in the gastrointestinal (GI) tract. During development, Sonic hedgehog (Shh) is highly expressed in the stomach and its expression
decreases along the intestine. Shh is expressed in the colon glands. Indian hedgehog (Ihh) expression peaks at the pyloric junction and is constant in the small intestine and colon.
There are no studies addressing the pattern of Desert hedgehog (Dhh) expression in the developing GI tract. The Hh receptor Patched (Ptch1) and the Glioblastoma (Gli)
transcriptional factor family proteins are expressed in the mesenchyme, mirroring Shh expression. In the adult GI tract, Shh expression is limited to the stomach and colon, with the
proximal stomach being themain source of themorphogen. Ihh is expressed in the small intestine, with highest levels in the proximal duodenum. Ihh is also expressed in the colonic
glands. Dhh expression has been reported in the gastric mucosa, but has not been localized in the small intestine. Ptch1, Gli proteins, and Smo are expressed primarily in the
mesenchyme of the adult GI tract.
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modulate parietal cell function, but not survival. The unresponsive-
ness of parietal cells to histamine, and the changes observed during
tubulovesicle formation in the Shh-depleted model [126] may be
associated with ezrin, a membrane cytoskeleton linker protein that
mobilizes H+,K+ATPase in the gastric parietal cells by a mechanism
dependent on PKA activation [130,131]. Although it has been shown
that gastrin regulates ezrin expression by parietal cells in gastrin
deﬁcient mice [132], the effects of hypergastrinemia on ezrin
expression and localization have not been yet studied.Table 1
Expression of Hedgehog related molecules in the stomach and gastric cancer.
Molecule Normal Stomach Intestinal
Metaplasia
Ca
Int
Shh Neck / Gland Epithelium Low or absent Hi
Ihh Pit Epithelium ND Hi
Dhh Gland Epithelium Low or absent Lo
Ptch1 Pit Mesenchyme D Hi
Smo Pit / Gland Mesenchyme D Hi
Gli1 Pit / Gland Mesenchyme Low or absent Hi
Gli2 Pit Mesenchyme Low or absent Hi
Hip D NR Lo
BOC Pit ND Hi
D: Detected, ND: Not detected, NR: Not reported, a: RT-PCR, b: Immunohistochemistry, c: IWe have demonstrated that the Shh 45 kDa form processing to the
19 kDa form in the stomach requires cleavage by pepsin A, which itself
requires acidic conditions tobecomeactive [22]. Acid is released into the
gastric lumen by parietal cells, making it available for pepsin A
activation. Thus in the stomach, we assume that Shh is released into
the lumen to be fully processed and active. However, Shh processing
within an acidic endocytic vesicle cannot be excluded. A recent study by
Robbins et al. has indicated that the unprocessed form of Shh has
biological activity [133]. Indeed, we found that the predominant formof
Shh in the transformed, hypochlorhydric stomach is the unprocessedncer Methods Reference
estinal Diffuse
gh Low or undetectable a, b [72]
a, b [193]
b [154]
a, b, c [123]
a [125]
gh Low a, b [72]
a, b, c [123]
w High a, b [72]
a, b, c [123]
a [125]
gh High a, b [72]
a, b, c [123]
a, d [125]
gh High a, b [72]
a, b, c [123]
gh High a, b [72]
a, b, c [123]
gh High a, b [72]
a, b, c [123]
w NR a, c [193]
gh High a, b [72]
mmunoﬂuorescence, d: LacZ reporter.
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responsive to Shh in vitro (unpublished data), raising the possibility that
Hh signaling can occur in through autocrine or non-canonical signaling.
Shh activation is acid-dependent in the stomach, therefore it has
been suggested that Shh is released at the apical surface of parietal
cells where acid is secreted [134]. Zymogenic, surface pit and mucous
neck cells also express Shh, however there is no data available on the
mechanism of Shh release from these cells. Recently, Etheridge et al.
have shown that Disp1 is required to produce and release Shh
basolaterally. Ptch1 in the adjacent cells binds to Shh, indicating that
both Ptch1 and Disp1 control the trafﬁcking of Shh away from its site
of synthesis [135]. If Hh signaling is paracrine with responsive cells
located exclusively in the mesenchyme, then the mechanism by
which secreted Shh is received by target cells might involve Disp1 and
will require further clariﬁcation. Megalin has been proposed as the
intracellular transporter for Shh in epithelial cells during develop-
ment and in the efferent duct epithelial cells of adult rat [136].
Megalin is involved in forming vesicles that deliver Shh to the basal
membrane of the producing cell [137]. However there is no evidence
that Shh-producing cells in the GI tract express megalin, raising the
possibility that ezrin could ﬁll that role in the stomach.
The eventual loss of zymogenic and mucous neck cell populations
in the Shh conditional null mouse suggests that Shh also affects the
trans-differentiation of mucous neck to zymogenic cells. Since the
helix-loop-helix transcription factor Mist1 mediates the transition of
this cell lineage in the gastric mucosa [138,139], Shh might modulate
the function of this transcription factor and subsequently the
appearance of these gastric cell types. Additional evidence supporting
a role for Shh in cell differentiation has emerged from studies of
aspirin-induced gastric ulceration in rats, which showed that Shh was
not required for cell proliferation, but rather for differentiation of
parietal, and mucous neck cells. By contrast, blocking Hh signaling
with cyclopamine, a Smo inhibitor increased the proliferation of
gastric progenitor cells without expansion of the parietal and mucous
neck cell compartments [59,140]. Other studies have shown that
cyclopamine treatment reduces the expression of H+,K+ATPase in
canine parietal cells [127] and mice hypergastrinemic stomach [140].
Collectively, these results suggest that Shh is necessary for progenitor
cell differentiation into various gastric cell lineages rather than
proliferation and for parietal cell function. Speciﬁcally, loss of Shh
expands the progenitor cell compartment at the expense of terminally
differentiated lineages [124,126].
Depleting Shh in the mouse parietal cells also induced expression
of Ihh, Gli1, TGF , Wnt, SNAIL, and cyclin-D1, while E-cadherin was
decreased [126]. Modulations in SNAIL and E-cadherin expression
have been associated with carcinogenesis, particularly in the intestine
and skin, where Hh activation induces SNAIL expression increasing its
metastatic potential [141,142]. Therefore one might consider that Shh
regulation of these genes, along with the associated changes in
proliferation and apoptosis, might explain mucosal transformation
during gastric carcinogenesis. Nevertheless, induction of Ihh did not
compensate for the loss of Shh in parietal cells. This result raises the
possibility that the three Hh proteins possess distinct functions in the
gastric mucosa, similar to their distinct roles in the hair follicle and the
sebaceous epithelial cell precursors of the skin [143,144].
H. pylori infection is the main cause of gastric inﬂammation, and
has a strong association with intestinal type gastric cancer develop-
ment in humans. Helicobacter-infection models in rodents have
provided valuable information on the early mechanisms involved in
gastric carcinogenesis and the participation of Shh in them. During
H. pylori infection, acid secretion by parietal cells is compromised and
Shh levels are reduced [145,146]. We have recently shown that IL-
1 also reduces Shh gene expression in parietal cells, H+,K+ATPase
expression and that gastric acid secretion subsequently blocks the
release of intracellular calcium [40]. Therefore, changes in gastric
acidity can result in the development of gastric atrophy, which in turncreates a permissive environment for the expression of intestine-
speciﬁc transcription factors, e.g., CDX2, which correlates with the
development metaplasia [147,148].
4.2. Shh in Gastric Cancer
Gastric cancers are classiﬁed histologically into two major types:
intestinal and diffuse [149]. The intestinal type is thought to develop
from a series of mucosal changes, triggered by chronic inﬂammation
(gastritis), then followed by parietal cell atrophy (atrophic gastritis),
gastric mucous cell hyperplasia, intestinal metaplasia, dysplasia, and
cancer [150]. On the other hand, diffuse gastric cancer is thought to
arise from deregulation of stem or precursor cells [151,152]. In
addition, the familial form of diffuse gastric cancer is due to mutations
in E-cadherin [153].
The two types of gastric cancer showdifferentHh ligand expression
proﬁles, perhaps due to their cell origin (See Table 1). The analysis of
human metaplastic and gastric cancer samples showed that the three
Hh ligands, Ptch1, Smo, and the three Gli transcription factors were
only weakly expressed or absent. In intestinal type gastric cancer, Ihh
and Shh expression were detected. However, the expression of Smo,
Gli 1, and 2 was infrequent but low when detectable [72].
Ihh, Shh, and Dhh expression was variable in diffuse gastric
cancers, but in contrast to the intestinal-type cancer, diffuse cancers
expressed high levels of Ptch1, Smo, and Gli proteins (Table 1). Some
diffuse cancer cells showed histological expression of Ihh, while Shh
expression was not detected in epithelial cells of the cancer, but
instead were expressed in the adjacent ﬁbroblast cells [123,154]. The
latter observation is suggestive of the Type IIIb signaling described by
de Sauvage and colleagues, in which the ligand is produced in the
supporting stromal cells [9,101]. Thus, some diffuse gastric cancers
belong to the Type IIIb group [125], while others might express
receptor mutations, or non-canonical pathway activation, as sug-
gested by the lack of response to cyclopamine-mediated inhibition of
Hh signaling [140,155], although these tumor types are rare. Gastric
metaplasia and intestinal cancer cannot be classiﬁed by these criteria
because they appear to involve the initial loss, then subsequent gain in
Hh signaling once the epithelium is irreversibly transformed
(Table 1). Therefore, we suggest adding a Type IV signaling pathway
to the classiﬁcation for cancers in which the normal adult epithelium
requires Hh signaling. With neoplastic transformation, Hh signaling is
lost, with or without gain of function mutations in the Hh signaling
molecules, e.g., Ptch1, Smo or the SuFu-Gli complex [140,155].
In summary, the normal gastric mucosa expresses Shh, Ihh and
Dhh (Table 1, Fig. 1). Shh regulates parietal, zymogenic, and mucous
neck cell differentiation, and proliferation, while Ihh appears to
modulate the surface pit cells without recapitulating the function of
Shh. The role of Dhh in the stomach is not yet known. During H. pylori
infection, Shh expression reduced by IL-1β results in the lack of acid
secretion and hypergastrinemia [40]. Even when gastrin stimulates
Shh expression, acid-dependent processing of the Shh precursor is
compromised, and parietal cells fail to become properly functional
[22], possibly due to changes in ezrin. Hypochlorhydria, hypergas-
trinemia, and low levels of Shh result in parietal cell atrophy, and
mucous cell expansion, with impaired zymogenic cell differentiation,
along with the expression of intestinal markers, such as Cdx2 and
Muc2, along with the expansion of cells with low Hh responsiveness
(low levels of Smo and Gli). Diffuse tumor carcinogenesis is associated
with hyperplasia of stem or precursor cells, but it is not yet clear
whether Hh signaling contributes to its pathogenesis. Although in
some of these tumors, the signaling shifts from its normal gastric
epithelial to a mesenchymal origin (Table 1). In addition, mutations in
the TGFβ growth factor receptor, activins, or mutations in Ptch1, Smo,
and other Hh pathway mediators such as Sufu or hedgehog
interacting protein (Hip), can result in constitutively active growth
signals.
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During gut development (reviewed in [156]), Hh signaling plays
an important role in the left-right axis speciﬁcation, radial patterning
by regulating villus formation, smooth muscle genesis, and develop-
ment of the enteric nervous system. At E11.5 and E12.5, Shh and Ihh
are expressed throughout the endoderm of the developing intestine.
Shh expression is down regulated in the small intestine at E14.5, with
the highest expression remaining in the duodenum. Ihh expression
remains unchanged in the developing intestine and colon. At E18.5
their expression is restricted to the intervillus epithelium in the small
intestine. In the colon, Shh is expressed at the base of the crypts,
whereas Ihh is expressed in surface colonocytes. Ptch1 and Gli1 are
exclusively expressed in the intestinal mesenchyme [71,157,158]. Shh
but not Ihh signaling is necessary for normal anorectal development
[3] (Fig. 1).
The adult small intestinal epithelium is established after the crypts
are completely formed by the third post-natal week. The level of Shh
mRNA in the adult small intestine and colon are very low compared to
those in the stomach, whereas Ihh expression appears to be more
robust, and present mainly at the crypt-villus junction [159]. Ptch1 is
expressed at low levels and only in the mesenchyme. The distal colon
expresses Ihh, but not Shh in epithelial colonocytes, and Ptch1
expression is also restricted to the mesenchyme underlying the Ihh
positive epithelium [157,158].
Both in vivo and in vitro studies show that Hh signaling is necessary
for enterocyte differentiation, such as brush border staining for villin,
and carbonic anhydrase IV [160]. Since Ptch1 expression is exclusively
mesenchymal, enterocyte differentiation must be either under
paracrine or non-canonical Hh regulation. In vitro, Hh signaling is
necessary and sufﬁcient for induction of differentiationmarkers in the
human colon adenocarcinoma HT-29 cell line [161], although these
cell lines express Ptch1 and Gli1 [162], suggesting autocrine reg-
ulation, which differs from what is currently understood regarding
Hh-mediated enterocyte differentiation.
Ulcerative colitis (UC), and Crohn's disease are the prevalent
inﬂammatory bowel disorders (IBD) with high morbidity. Lees et al.
analyzed samples of human colonic inﬂammation and found that the
levels of Gli1, Ptch1, Hip, and Ihh were lower in UC patients. They also
identiﬁed a germ line variation in Gli1 that resulted in reduced Hh
signaling. In vivo analysis of mice heterozygous for Gli1 demonstrated
increased acute inﬂammation when the mice were treated with
dextran sulfate (DSS). These authors found that Hh signaling also
regulates myeloid cells, including dendritic cells in the colon, during
both homeostasis and under inﬂammatory conditions [163].
The association of Hh signaling with cancers of the intestine or
colon is controversial. Mouse models with deleted or silenced Hh
signaling molecules that have been analyzed thus far do not develop
gastrointestinal cancers, except in the pancreas (reviewed in [122],
and [164]). Some reports show that expression of Hh signaling com-
ponents is increased in hyperplastic polyps, adenomas and adeno-
carcinomas of the human colon. These Hh components are also
expressed in many colon adenoma or adenocarcinoma cell lines
[165,166]. In contrast, it has been reported that Ihh antagonizes Wnt
signaling in a colon cancer cell line and that loss of Ihh contributes to
intestinal tumor formation [160]. Transgenic expression of the Hh
ligand-inhibitor Hip in the small intestine also enhances activation of
Wnt signaling. In addition, treatment with cyclopamine does not alter
the expression of Ptch1 and Gli1 in some colon cell lines [158].
Therefore, Hh participation in colon cancer development might occur
by enhancing or inhibiting the Wnt pathway [167].
The distal colon looses Ihh expression early in the process of the
adenoma to carcinoma sequence of colorectal cancer. Ihh expression
loss is caused by mutations in adenomatous polyposis coli (APC) or
other genes that result in uncontrolled Wnt pathway activity
[160,167,168]. Recently, Smo was found to contribute to intestinaltumorigenesis by increasing Wnt signaling, in the APC mutant mice
treated with cyclopamine, and this role was conﬁrmed by further
speciﬁc deletion of Smo in the intestine of these mice [167]. Indeed,
Smo expression is high in adenomatous polyps with APC mutations
compared to normal intestine where it is hardly detectable. Smo can
stimulate intestinal tumor cell proliferation by increasing -catenin in
the intestinal tumor cells, altering the β-catenin/Tcf dependent Wnt
signaling, resulting in the expression of Wnt targets, Gli independent
or non-canonical Hh signaling [169]. Collectively, these data suggest
that Hh signaling is important for normal enterocyte differentiation,
and its role in intestinal or colon cancer development is not direct,
involving both mesenchymal paracrine signaling [170] and Hh
pathway molecules acting in Wnt signaling [171,172].
4.4. Esophagus, pancreas and liver
Hh signaling in the esophagus during development mirrors the
observed expression in the stomach. The esophagus consists of three
to four layers of squamous epithelium. During development at E17,
some ciliated cells are also observed, however the ciliated cells
disappear 1 week after birth [173]. Human and mice esophageal
epithelia differ in that the mouse esophagus becomes keratinized one
month after birth, while the human esophagus is not keratinized
[174]. In the human adult esophagus, Shh expression is restricted to
the basal cell layer, while Dhh is expressed in differentiated cells and
Ihh is absent. Gli1 expression was localized in the nuclei of the basal
and parabasal cells, and keratinocytes differentiation is blocked by
cyclopamine, suggesting Hh signaling is necessary for epithelium
differentiation but absent in differentiated cells [175]. Hh signaling is
activated in most esophageal squamous cells carcinomas, along with
several markers of epithelial-mesenchymal transformation (EMT)
that are regulated by Gli1 [175], suggesting that esophageal
carcinomas arise from aberrant Hh signaling cross-talk between the
mesenchyme and epithelium. However the information available on
these carcinomas and Hh signaling is scarce.
The pancreas represents an interesting and controversial organ in
terms of Hh signaling. In contrast to the other organs mentioned in
this review, Shh expression is absent in the embryonic pancreatic bud
[176,177]. Ihh, Dhh and Ptch1 are expressed in the pancreas from
embryonic day 13.5 onward, and their expression remains constant in
adult islet and duct cells [178,179]. Activated Hh signaling in the
developing pancreas results in loss of endocrine cells [177] while
models where Hh signaling is lost, result in an expansion of the
pancreas [178,180]. Recently, Hebrok and colleagues demonstrated
that Hh signaling is active in the pancreatic epithelium during de-
velopment, and Smo mutant mice are glucose intolerant and produce
less insulin [181]. Therefore Hh signaling in the developing pancreas is
required for endocrine function. Hh signaling in pancreatic cancer has
been widely studied. Teglund et al. recently published a comprehen-
sive review of Hh signaling and pancreatic cancer, among other forms
of cancer [182]. In summary, most of the studies report the expression
of both Shh and Ihh in pancreatic cancer. Apparently, Shh ligand is
expressed transiently in the injured pancreas, but remains “on” in the
transforming pancreas (intraepithelial neoplasia PanIN) suggesting
aberrant Hh pathway activation in the pancreas contributing to cancer
development. However Hh signaling alterations are not sufﬁcient
cause cancer and mutation of oncogenes, i.e. Kras, are necessary for
pancreatic cancer development.
There is little information about Hh signaling in the liver. Hepatic
stellate cells and liver epithelial progenitor cells express and respond
to Hh ligands [183–185]. Activation of Hh signaling has been reported
in hepatocellular carcinoma [186,187] and Hh signaling in the liver
appears to be related to EMT involving the transformation of qui-
escent stellate cells to myoﬁbroblastic stellate cells, via the reduction
of Hip expression, as evidenced in a model of induced cirrhosis [188].
Thus the development of hepatocellular carcinoma involves cross-talk
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exclusively to alterations in Hh signaling.
4.5. Future directions
Hh signaling is extremely complex. Recent studies have highlight-
ed the importance of different pathway members, namely Smo, Sufu,
Kif7, Disp1, and other participants, such as primary cilia, proteogly-
cans, and heparan sulfate, in Hh signaling regulation. Nevertheless, we
still lack a complete understanding of the mechanisms involving Hh
signaling.
The roles of Ihh and Dhh in the gastrointestinal mucosa, and
mesenchyme have yet to be resolved. There are reports of Ihh and Dhh
expression in the gastrointestinal epithelium, but one should exercise
cautionwhen analyzing these often-contradictory studies. Most of the
antibodies commercially available for Hh ligands cross-react with the
other family members, and reports using antibodies against Ptch1 and
Gli proteins are not consistent, nor are those antibodies commercially
available. Arguably, the best tool available to analyze Hh mRNA
expression in vivo is in-situ hybridization. This technology has proven
very powerful, in particular to establish the localization of Hh ligand
and signaling molecules, e.g., Shh in the stomach, in contrast to Ihh
expression in the distal intestine and colon. Nevertheless following
the corresponding proteins has been problematic using antibodies.
Transgenic reporter mice have also provided important insight;
however, complete null mice are not suitable for adult tissue analysis
due to the critical role of Hh signaling in development. Conditional
and inducible deletion models are available for analysis in the
intestine due to the existence of well-characterized tissue speciﬁc
promoters to express Cre recombinase. However, stomach-speciﬁc
promoters are limited, making development of deletion models a
challenge for the ﬁeld.
Finally, the duration of Hh signaling might be tissue speciﬁc. In the
skin, Shh is transiently expressed in periods of hair active growth
when Hh signaling is intermittent [189]. During development, Hh
signaling is active in the intestinal tract, but in the adult, intestinal Hh
signaling is due to Ihh rather than Shh. Shh expression is constant in
the stomach, as are Ihh and Dhh. Depletion of Shh expression results
in an increase in Ihh expression without apparent functional overlap
[126]. The turnover time for each cell type in the stomach is different,
ranging from 4 days for mucous cells to close to 60 days for parietal
cells [190–192]. Shh is important in proliferation and the differenti-
ation of gastric cell types but, to our knowledge, there are no studies
on the expression of different Hh ligands over time in the adult gastric
mucosa. Hh proteinsmay exert differential roles related to speciﬁc cell
turnover cycles, but that concept has yet to be explored.
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